Autonomix Medical, Inc. (AMIX) just unveiled an announcement.
Autonomix Medical, Inc. has reported encouraging early results from a clinical trial assessing a new treatment that could alleviate pancreatic cancer pain by targeting specific nerves. The announcement, made on June 18, 2024, highlighted the success of the first five patients in a proof-of-concept study. These findings were also presented in a webcast, underlining the company’s progress in developing potentially groundbreaking pain mitigation therapies.
See more data about AMIX stock on TipRanks’ Stock Analysis page.